Perimeter Medical Imaging AI (PINK) Status Update summary

Problem and market overview

• High rates of positive margins in cancer surgery lead to costly and emotionally taxing re-operations, especially in breast cancer, where 23% of lumpectomies require additional surgery.

• Repeat surgeries increase post-op complications by 66%, delay further treatment, and strain hospital resources.

• The economic burden is significant, with $700 million annually spent on breast lumpectomy re-excisions in the US alone.

Technology and clinical impact

• The core technology is wide-field optical coherence tomography (OCT), offering 10-100x higher resolution than traditional imaging.

• Real-time imaging enables surgeons to assess margins intraoperatively, reducing re-operation rates to as low as 5.6% in early cohorts.

• AI-powered ImageAssist further enhances efficiency and accuracy, with a large proprietary image library supporting ongoing algorithm improvements.

• A recent multi-site clinical trial met its primary endpoint, showing statistically significant reduction in positive margins.

Commercial strategy and business model

• The S-Series device is placed in operating rooms at no charge, monetized through high-margin single-use consumables (~$1,000 each, 90%+ margin).

• A service contract and future software subscription model are being added, with plans to sell or lease devices as market power grows.

• Hospitals are incentivized by improved patient outcomes and competitive differentiation, despite current reimbursement limitations.